世界のロタウイルスワクチン市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20DC8132)
◆英語タイトル:Global Rotavirus Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20DC8132
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年12月(※2023年版があります。お問い合わせください。)
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥480,240見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥720,360見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥960,480見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ロタウイルスワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ロタウイルスワクチンの種類別市場規模(5価経口、経口)、用途別市場規模(政府機関、民用、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Merck、Lanzhou Institution、GSK、Sanofi、
・地域別グローバル市場分析 2015年-2020年
・ロタウイルスワクチンの北米市場(アメリカ、カナダ、メキシコ)
・ロタウイルスワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ロタウイルスワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ロタウイルスワクチンの南米市場(ブラジル、アルゼンチン)
・ロタウイルスワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:5価経口、経口
・用途別分析:政府機関、民用、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Rotavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Rotavirus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Rotavirus Vaccine market has been segmented into
Pentavalent Oral
Oral

By Application, Rotavirus Vaccine has been segmented into:
Government Institution
Private Sector
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rotavirus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Rotavirus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rotavirus Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Rotavirus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Rotavirus Vaccine Market Share Analysis
Rotavirus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rotavirus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rotavirus Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Rotavirus Vaccine are:
Merck
Lanzhou Institution
GSK
Sanofi

Among other players domestic and global, Rotavirus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rotavirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rotavirus Vaccine, with price, sales, revenue and global market share of Rotavirus Vaccine in 2018 and 2019.
Chapter 3, the Rotavirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Rotavirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rotavirus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Pentavalent Oral
1.2.3 Oral
1.3 Market Analysis by Application
1.3.1 Overview: Global Rotavirus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Overview of Global Rotavirus Vaccine Market
1.4.1 Global Rotavirus Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lanzhou Institution
2.2.1 Lanzhou Institution Details
2.2.2 Lanzhou Institution Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lanzhou Institution SWOT Analysis
2.2.4 Lanzhou Institution Product and Services
2.2.5 Lanzhou Institution Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Rotavirus Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Rotavirus Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Rotavirus Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Rotavirus Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Rotavirus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Rotavirus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Rotavirus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.4 France Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Rotavirus Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.5 India Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Rotavirus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Rotavirus Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Rotavirus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Rotavirus Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Rotavirus Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Rotavirus Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Rotavirus Vaccine Price by Type (2015-2020)
11 Global Rotavirus Vaccine Market Segment by Application
11.1 Global Rotavirus Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Rotavirus Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Rotavirus Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Rotavirus Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Rotavirus Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Rotavirus Vaccine Market Forecast (2021-2025)
12.2.2 Europe Rotavirus Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Rotavirus Vaccine Market Forecast (2021-2025)
12.2.4 South America Rotavirus Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Rotavirus Vaccine Market Forecast (2021-2025)
12.3 Rotavirus Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Rotavirus Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Rotavirus Vaccine Market Share Forecast by Type (2021-2025)
12.4 Rotavirus Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Rotavirus Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Rotavirus Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Merck、Lanzhou Institution、GSK、Sanofi、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のロタウイルスワクチン市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Rotavirus Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。